Related references
Note: Only part of the references are listed.Single and repeated ketamine treatment induces perfusion changes in sensory and limbic networks in major depressive disorder
Ashish K. Sahib et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
Maurizio Fava et al.
MOLECULAR PSYCHIATRY (2020)
Overlap in the neural circuitry and molecular mechanisms underlying ketamine abuse and its use as an antidepressant
Saurabh S. Kokane et al.
BEHAVIOURAL BRAIN RESEARCH (2020)
Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects
Allison C. Nugent et al.
MOLECULAR PSYCHIATRY (2019)
Repeated oral ketamine for out-patient treatment of resistant depression: randomised, double-blind, placebo-controlled, proof-of-concept study
Yoav Domany et al.
BRITISH JOURNAL OF PSYCHIATRY (2019)
Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial
Dawn F. Ionescu et al.
JOURNAL OF AFFECTIVE DISORDERS (2019)
Fast-acting antidepressant activity of ketamine: highlights on brain serotonin, glutamate, and GABA neurotransmission in preclinical studies
Thu Ha Pham et al.
PHARMACOLOGY & THERAPEUTICS (2019)
Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study
Vanina Popova et al.
AMERICAN JOURNAL OF PSYCHIATRY (2019)
Identifying Ketamine Responses in Treatment-Resistant Depression Using a Wearable Forehead EEG
Zehong Cao et al.
IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING (2019)
Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)
Maggie Fedgchin et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2019)
Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial
Michael F. Grunebaum et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
The Effect of a Single Dose of Intravenous Ketamine on Suicidal Ideation: A Systematic Review and Individual Participant Data Meta-Analysis
Samuel T. Wilkinson et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Does oral administration of ketamine accelerate response to treatment in major depressive disorder? Results of a double-blind controlled trial
Somaye Arabzadeh et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Persistent antidepressant effect of low-dose ketamine and activation in the supplementary motor area and anterior cingulate cortex in treatment-resistant depression: A randomized control study
Mu-Hong Chen et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
Panos Zanos et al.
PHARMACOLOGICAL REVIEWS (2018)
Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression A Randomized Clinical Trial
Ella J. Daly et al.
JAMA PSYCHIATRY (2018)
Cognitive function of patients with treatment-resistant depression after a single low dose of ketamine infusion
Mu-Hong Chen et al.
JOURNAL OF AFFECTIVE DISORDERS (2018)
Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression
Wei Zheng et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2018)
Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Spencer L. G. James et al.
LANCET (2018)
Ketamine augmentation for outpatients with treatment-resistant depression: Preliminary evidence for two-step intravenous dose escalation
Cristina Cusin et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2017)
Low-dose ketamine for treatment resistant depression in an academic clinical practice setting
David Feifel et al.
JOURNAL OF AFFECTIVE DISORDERS (2017)
Ketamine for Depression, 4: In What Dose, at What Rate, by What Route, for How Long, and at What Frequency?
Chittaranjan Andrade
JOURNAL OF CLINICAL PSYCHIATRY (2017)
Oral Ketamine in Treatment-Resistant Depression: A Clinical Effectiveness Case Series
Maryam I. Al Shirawi et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2017)
Dose-Related Effects of Adjunctive Ketamine in Taiwanese Patients with Treatment-Resistant Depression
Tung-Ping Su et al.
NEUROPSYCHOPHARMACOLOGY (2017)
Ketamine Increases the Function of γ-Aminobutyric Acid Type A Receptors in Hippocampal and Cortical Neurons
Dian-Shi Wang et al.
ANESTHESIOLOGY (2017)
Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis
Ying Xu et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2016)
Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study
Y. -D. Hu et al.
PSYCHOLOGICAL MEDICINE (2016)
A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression
Jaskaran B. Singh et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy
Marko A. Peltoniemi et al.
CLINICAL PHARMACOKINETICS (2016)
KETAMINE FOR TREATMENT-RESISTANT UNIPOLAR AND BIPOLAR MAJOR DEPRESSION: CRITICAL REVIEW AND IMPLICATIONS FOR CLINICAL PRACTICE
William V. Bobo et al.
DEPRESSION AND ANXIETY (2016)
Comparing the actions of lanicemine and ketamine in depression: key role of the anterior cingulate
Darragh Downey et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2016)
Efficacy and safety of oral ketamine versus diclofenac to alleviate mild to moderate depression in chronic pain patients: A double-blind, randomized, controlled trial
Morteza Jafarinia et al.
JOURNAL OF AFFECTIVE DISORDERS (2016)
Continuation phase intravenous ketamine in adults with treatment resistant depression
Jennifer L. Vande Voort et al.
JOURNAL OF AFFECTIVE DISORDERS (2016)
Rapid and Sustained Reductions in Current Suicidal Ideation Following Repeated Doses of Intravenous Ketamine: Secondary Analysis of an Open-Label Study
Dawn F. Ionescu et al.
JOURNAL OF CLINICAL PSYCHIATRY (2016)
A mega-analysis of fixed-dose trials reveals dose-dependency and a rapid onset of action for the antidepressant effect of three selective serotonin reuptake inhibitors
F. Hieronymus et al.
TRANSLATIONAL PSYCHIATRY (2016)
The use of ketamine as an antidepressant: a systematic review and meta-analysis
Caoimhe M. Coyle et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2015)
Meta-analysis of short- and mid-term efficacy of ketamine in unipolar and bipolar depression
Bruno Romeo et al.
PSYCHIATRY RESEARCH (2015)
Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial
J. W. Murrough et al.
PSYCHOLOGICAL MEDICINE (2015)
Ketamine for the Treatment of Depression in Patients Receiving Hospice Care: A Retrospective Medical Record Review of Thirty-One Cases
Alana Iglewicz et al.
PSYCHOSOMATICS (2015)
A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes
A. McGirr et al.
PSYCHOLOGICAL MEDICINE (2015)
A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder
Kyle A. B. Lapidus et al.
BIOLOGICAL PSYCHIATRY (2014)
Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression
Paulo R. Shiroma et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2014)
Do the dissociative side effects of ketamine mediate its antidepressant effects?
David A. Luckenbaugh et al.
JOURNAL OF AFFECTIVE DISORDERS (2014)
Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
James W. Murrough et al.
AMERICAN JOURNAL OF PSYCHIATRY (2013)
Neural Correlates of Rapid Antidepressant Response to Ketamine in Treatment-Resistant Unipolar Depression: A Preliminary Positron Emission Tomography Study
Paul J. Carlson et al.
BIOLOGICAL PSYCHIATRY (2013)
Rapid and Longer-Term Antidepressant Effects of Repeated Ketamine Infusions in Treatment-Resistant Major Depression
James W. Murrough et al.
BIOLOGICAL PSYCHIATRY (2013)
Daily Oral Ketamine for the Treatment of Depression and Anxiety in Patients Receiving Hospice Care: A 28-Day Open-Label Proof-of-Concept Trial
Scott A. Irwin et al.
JOURNAL OF PALLIATIVE MEDICINE (2013)
Serial infusions of low-dose ketamine for major depression
Keith G. Rasmussen et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2013)
Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial
Carlos A. Zarate et al.
BIOLOGICAL PSYCHIATRY (2012)
Signaling pathways underlying the rapid antidepressant actions of ketamine
Ronald S. Duman et al.
NEUROPHARMACOLOGY (2012)
Star-D: lessons learned and future implications
A. John Rush
DEPRESSION AND ANXIETY (2011)
A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression
Nancy Diazgranados et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Safety and Efficacy of Repeated-Dose Intravenous Ketamine for Treatment-Resistant Depression
Marije aan het Rot et al.
BIOLOGICAL PSYCHIATRY (2010)
Oral Ketamine for the Rapid Treatment of Depression and Anxiety in Patients Receiving Hospice Care
Scott A. Irwin et al.
JOURNAL OF PALLIATIVE MEDICINE (2010)
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
David Moher et al.
INTERNATIONAL JOURNAL OF SURGERY (2010)
Development of a Sublingual/Oral Formulation of Ketamine for Use in Neuropathic Pain Preliminary Findings from a Three-Way Randomized, Crossover Study
Chui Chong et al.
CLINICAL DRUG INVESTIGATION (2009)
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression
Carlos A. Zarate et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Onset of action of escitalopram compared with other antidepressants: results of a pooled analysis
S Kasper et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2006)
Antidepressants and the risk of suicidal behaviors
H Jick et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Can we individualize the number needed to treat? An empirical study of summary effect measures in meta-analyses
TA Furukawa et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2002)
Attenuation of ketamine effects by nimodipine pretreatment in recovering ethanol dependent men: Psychopharmacologic implications of the interaction of NMDA and L-type calcium channel antagonists
EM Krupitsky et al.
NEUROPSYCHOPHARMACOLOGY (2001)
Antidepressant effects of ketamine in depressed patients
RM Berman et al.
BIOLOGICAL PSYCHIATRY (2000)
Share Paper
